Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Minnesota
Age
25–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Simultaneous co-enrollment in the START study
Signed informed consent to the Pulmonary Substudy
Age \>= 25 years
You may not be if
An episode of respiratory illness with 2 or more symptoms of cough, wheezing, breathlessness, or increase in sputum production within the 6 weeks before baseline spirometry.
Use of asthma medications (bronchodilator, inhaled corticosteroid, leukotriene inhibitor, or theophylline) for 2 or more consecutive weeks within the 6 months before baseline spirometry.
Relative contraindications to spirometry, such as chest or abdominal or eye surgery within the 3 months before baseline spirometry, known retinal detachment at the time of baseline spirometry.
Known allergy to albuterol/salbutamol
Relative contraindications to albuterol/salbutamol, such as resting heart rate of \>110 beats per minute, or a known serious or recurrent or uncontrolled cardiac condition (such as unstable coronary artery disease, decompensated heart failure, or recurrent tachyarrhythmias).
Clareo Health | Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
